Technologies related to NEI

Use of Interleukin (IL)-34 to Treat Retinal Inflammation and Neurodegeneration
Ref: E-091-2018 | Updated: Jun 28, 2019
Treatment of Oculocutaneous/Ocular Albinism and for Increasing Pigmentation
Ref: E-113-2010 | Updated: May 10, 2019
Metformin for the Treatment of Age-related Retinal Degeneration
Ref: E-227-2018 | Updated: May 15, 2019
Strategies to Protect Mammalian Neural Tissue Against Cold and Potentially Other Metabolic Stresses and Physical Damages
Ref: E-165-2017 | Updated: Oct 12, 2018
Ex-vivo Production of Regulatory B-Cells for Use in Auto-immune Diseases
Ref: E-036-2012 | Updated: Apr 23, 2018
Bone Marrow Mesenchymal Stem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma
Ref: E-044-2018 | Updated: Aug 16, 2018
3D Vascularized Human Ocular Tissue for Cell Therapy and Drug Discovery
Ref: E-004-2017 | Updated: Aug 16, 2018
Method for Reproducible Differentiation of Clinical Grade Retinal Pigment Epithelium Cells
Ref: E-212-2015 | Updated: Aug 14, 2018
Machine Learning and/or Neural Networks to Validate Stem Cells and Their Derivatives for Use in Cell Therapy, Drug Delivery, and Diagnostics
Ref: E-058-2018 | Updated: Aug 14, 2018
Methods and Compositions for Treating Genetically Linked Diseases of the Eye
Ref: E-284-2012 | Updated: Jul 27, 2018
Interleukin 24 (IL-24) to treat inflammatory diseases
Ref: E-119-2017 | Updated: Jul 19, 2018
Establishment of Induced Pluripotent Stem Cells (iPSC) from the Thirteen-lined Ground Squirrel
Ref: E-059-2017 | Updated: Jun 26, 2018
RP2 and RPGR Vectors For Treating X-linked Retinitis Pigmentosa
Ref: E-050-2015 | Updated: Jun 1, 2018
Surgical Tool for Sub-retinal Tissue Implantation
Ref: E-192-2014 | Updated: Jul 19, 2018
Selective Estrogen-Receptor Modulators (SERMs) Confer Protection Against Photoreceptor Degeneration
Ref: E-134-2016/0 | Updated: Jun 22, 2017
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
Ref: E-134-2016 | Updated: Jun 22, 2017
Devices for Improved Tissue Cryopreservation and Recovery
Ref: E-094-2016/0 | Updated: Apr 18, 2017
Devices for Improved Tissue Cryopreservation and Recovery
Ref: E-094-2016 | Updated: Apr 14, 2017
Tissue Clamp for Repeated Opening and Closure of Incisions/Wounds
Ref: E-293-2016 | Updated: Feb 17, 2018
Transgenic Mouse Model of Human Open Angle Glaucoma
Ref: E-091-2015/0 | Updated: Jul 2, 2015
IFN Gamma for Reducing Adverse Ocular Side Effects of MEK-Inhibitor Therapy in Cancer
Ref: E-248-2012/0 | Updated: Jul 1, 2015
Ex-vivo Production of Regulatory B-Cells (Breg) for Use in Auto-immune Indications
Ref: E-036-2012/0 | Updated: Apr 15, 2014
Surgical Tool for Ocular Tissue Transplantation
Ref: E-105-2013/0 | Updated: Nov 13, 2013
Novel Methods for Generating Retinal Pigment Epithelium Cells from Induced Pluripotent Stem Cells
Ref: E-251-2012/3 | Updated: May 31, 2013
Use of Sterculic Acid to Treat Choroidal Neovascularization
Ref: E-092-2010/0 | Updated: Jan 24, 2018
Nitisinone for Treatment of Oculocutaneous/Ocular Albinism and for Increasing Pigmentation
Ref: E-113-2010/0 | Updated: Jan 6, 2011
Immortalized Transformed Lymphoblastoid Cell Lines from Patients with François-Neetens Mouchetée Fleck Corneal Dystrophy (CFD)
Ref: E-270-2009/0 | Updated: Sep 23, 2009
Methods for Using Interferon Gamma to Absorb Fluid From the Subretinal Space
Ref: E-169-2008/0 | Updated: Nov 1, 2008
Treatment and Prevention of Age-Related Macular Degeneration and Other Eye-Related Diseases
Ref: E-056-2008/0 | Updated: Nov 1, 2008
Identification and Isolation of the Receptor for Pigment Epithelium-derived Factor (PEDF)
Ref: E-314-2003-0 | Updated: May 7, 2018
Devices for Aseptic Lyophilization of Biological Samples
Ref: E-015-1995/2 | Updated: Sep 1, 2006
cDNA for Murine PEDF
Ref: E-112-2004-0 | Updated: May 10, 2018
Ocular Therapeutic Agent Delivery Devices And Methods
Ref: E-241-1999-0 | Updated: May 10, 2018
Immunoadhesins and Methods of Production Thereof
Ref: E-127-1996/0 | Updated: Jul 1, 1999
Animal Model for Age-Related Macular Degeneration and Methods for Use Thereof
Ref: E-078-1997/0 | Updated: Sep 1, 1998
Macrophage Migration Inhibitory Factor (MIF)
Ref: E-090-1991/0 | Updated: May 1, 1997
Pigment Epithelium Derived Factor: Characterization of Its Novel Biological Activity and Sequences Encoding and Expressing the Protein
Ref: E-185-1992-1 | Updated: May 14, 2018
Subscribe to Technologies related to NEI